Please ensure Javascript is enabled for purposes of website accessibility
Accueil > Support > Références

Engineering high-affinity dual targeting cellular nanovesicles for optimised cancer immunotherapy

Date de publication : 2023-11-16  Nombre de vues : 23
Recommandation

Obtenir un devis gratuit